Atrovent, Spiriva Safety To Be Tracked In Pharmacy Active Surveillance Pilot
Executive Summary
An active drug surveillance system pilot, directed by the Critical Path Institute (C-Path), will track safety and efficacy information for the chronic obstructive pulmonary disorder therapies Atrovent and Spiriva
You may also be interested in...
Public/Private Partnership Is Best Vehicle For Active Rx Surveillance System
An active drug safety surveillance system is "doable," and would cost in the tens of millions of dollars, GlaxoSmithKline Chief Medical Officer Ronald Krall said during a recent Institute of Medicine symposium on the future of drug safety
Public/Private Partnership Is Best Vehicle For Active Rx Surveillance System
An active drug safety surveillance system is "doable," and would cost in the tens of millions of dollars, GlaxoSmithKline Chief Medical Officer Ronald Krall said during a recent Institute of Medicine symposium on the future of drug safety
One Year After Vioxx, Pendulum May Be Swinging Back To Efficacy At FDA
One year after the withdrawal of Vioxx, FDA appears to be rebalancing its focus from a heightened emphasis on safety towards a greater appreciation of the emerging efficacy of drugs